PDB Short entry for 1XE6 HEADER HYDROLASE/HYDROLASE INHIBITOR 09-SEP-04 1XE6 TITLE STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ASPARTIC HEMOGLOBINASE II, PFAPD; COMPND 5 EC: 3.4.23.39 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.PRADE REVDAT 3 13-JUL-11 1XE6 1 VERSN REVDAT 2 24-FEB-09 1XE6 1 VERSN REVDAT 1 23-AUG-05 1XE6 0 JRNL AUTH L.PRADE JRNL TITL STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN JRNL TITL 2 ANALOGUE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 25357 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1353 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1120 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE SET COUNT : 60 REMARK 3 BIN FREE R VALUE : 0.3610 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 37 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.03000 REMARK 3 B22 (A**2) : 4.03000 REMARK 3 B33 (A**2) : -6.05000 REMARK 3 B12 (A**2) : 2.02000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.726 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.356 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.300 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.733 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5444 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7418 ; 1.514 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 656 ; 7.658 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 854 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4120 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2289 ; 0.225 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 167 ; 0.139 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 42 ; 0.227 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.159 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3272 ; 1.425 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5330 ; 2.459 ; 4.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2172 ; 1.307 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2088 ; 2.036 ; 4.000 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XE6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-SEP-04. REMARK 100 THE RCSB ID CODE IS RCSB030260. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27929 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 119.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.11900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.45833 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.91667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.91667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.45833 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 13 -21.41 69.12 REMARK 500 ILE A 14 -87.09 -75.95 REMARK 500 GLN A 27 82.73 50.48 REMARK 500 ASP A 69 -73.85 -164.26 REMARK 500 ASP A 89 178.96 175.25 REMARK 500 LYS A 163 -90.29 -93.27 REMARK 500 LEU A 191 -85.60 -131.91 REMARK 500 VAL A 201 -57.05 -124.11 REMARK 500 ALA A 219 -167.07 -120.21 REMARK 500 GLN A 232 -76.28 7.24 REMARK 500 ASN A 251 103.42 -52.18 REMARK 500 GLU A 271 -6.61 -48.08 REMARK 500 ASN A 288 48.31 -73.02 REMARK 500 PRO A 297 125.95 -37.75 REMARK 500 SER B 2 18.71 -162.49 REMARK 500 GLN B 26 -89.86 -50.04 REMARK 500 GLN B 27 80.95 47.45 REMARK 500 LYS B 68 153.13 -46.76 REMARK 500 ASP B 69 -59.23 -151.80 REMARK 500 ASP B 89 178.44 176.73 REMARK 500 LEU B 126 28.60 -141.55 REMARK 500 SER B 135 83.17 23.83 REMARK 500 ASN B 147 39.18 28.18 REMARK 500 GLU B 150 -70.75 -52.25 REMARK 500 LEU B 191 -90.06 -127.33 REMARK 500 TRP B 193 80.57 -67.07 REMARK 500 PRO B 240 -66.15 -28.24 REMARK 500 PRO B 243 44.17 -77.81 REMARK 500 LYS B 253 20.22 -75.28 REMARK 500 ASN B 288 18.43 56.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN B 233 25.0 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3- REMARK 630 HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- REMARK 630 BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]- REMARK 630 PENTANOIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 5FP A 400 REMARK 630 5FP B 400 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: IVA VAL VAL F3T ALA F3T REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5FP A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5FP B 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XDH RELATED DB: PDB REMARK 900 RELATED ID: 1XE5 RELATED DB: PDB REMARK 900 THE SAME PROTEIN AT 2.4 A DBREF 1XE6 A 1 329 UNP P46925 PLM2_PLAFA 125 453 DBREF 1XE6 B 1 329 UNP P46925 PLM2_PLAFA 125 453 SEQRES 1 A 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 A 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 A 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 A 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 A 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 A 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 A 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 A 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 A 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 A 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 A 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 A 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 A 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 A 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 A 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 A 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 A 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 A 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 A 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 A 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 A 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 A 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 A 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 A 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 A 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 A 329 LYS LYS ASN LEU SEQRES 1 B 329 SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE GLN ASN SEQRES 2 B 329 ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP ASN GLN SEQRES 3 B 329 GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER ALA ASN SEQRES 4 B 329 LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA GLY CYS SEQRES 5 B 329 LEU THR LYS HIS LEU TYR ASP SER SER LYS SER ARG THR SEQRES 6 B 329 TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN TYR VAL SEQRES 7 B 329 SER GLY THR VAL SER GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 B 329 THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 B 329 VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR THR ALA SEQRES 10 B 329 SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 B 329 LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL GLU LEU SEQRES 12 B 329 LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE THR PHE SEQRES 13 B 329 TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE LEU THR SEQRES 14 B 329 ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY PRO LEU SEQRES 15 B 329 THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP GLN ILE SEQRES 16 B 329 THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU GLU LYS SEQRES 17 B 329 ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA ILE THR SEQRES 18 B 329 VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN ASN LEU SEQRES 19 B 329 ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR VAL THR SEQRES 20 B 329 LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU PHE THR SEQRES 21 B 329 SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 B 329 LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU CYS MET SEQRES 23 B 329 LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO THR PHE SEQRES 24 B 329 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 B 329 PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA LEU ALA SEQRES 26 B 329 LYS LYS ASN LEU HET 5FP A 400 48 HET 5FP B 400 48 HETNAM 5FP 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3- HETNAM 2 5FP HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL- HETNAM 3 5FP BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- HETNAM 4 5FP PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID FORMUL 3 5FP 2(C28 H45 F6 N5 O9) FORMUL 5 HOH *37(H2 O) HELIX 1 1 THR A 49 LYS A 55 5 7 HELIX 2 2 ASP A 59 SER A 63 5 5 HELIX 3 3 THR A 108 GLU A 112 5 5 HELIX 4 4 PRO A 113 SER A 118 1 6 HELIX 5 5 TRP A 128 SER A 132 5 5 HELIX 6 6 PRO A 138 GLN A 146 1 9 HELIX 7 7 PRO A 223 GLN A 232 1 10 HELIX 8 8 GLU A 269 TYR A 273 1 5 HELIX 9 9 ASP A 303 LYS A 308 1 6 HELIX 10 10 GLY B 51 LYS B 55 5 5 HELIX 11 11 THR B 108 GLU B 112 5 5 HELIX 12 12 PRO B 113 SER B 118 1 6 HELIX 13 13 PRO B 138 GLN B 146 1 9 HELIX 14 14 PRO B 223 GLN B 232 1 10 HELIX 15 15 GLU B 269 LEU B 274 1 6 HELIX 16 16 GLY B 302 LYS B 308 1 7 SHEET 1 A 9 LYS A 72 TYR A 77 0 SHEET 2 A 9 GLY A 80 VAL A 93 -1 O GLY A 80 N TYR A 77 SHEET 3 A 9 MET A 15 GLU A 21 -1 N GLU A 21 O THR A 92 SHEET 4 A 9 ASP A 4 PHE A 11 -1 N PHE A 11 O MET A 15 SHEET 5 A 9 GLY A 166 ILE A 170 -1 O GLY A 166 N LEU A 8 SHEET 6 A 9 LEU A 153 TYR A 157 -1 N THR A 155 O THR A 169 SHEET 7 A 9 TYR A 309 ASP A 314 -1 O PHE A 313 N PHE A 154 SHEET 8 A 9 SER A 319 LEU A 324 -1 O GLY A 321 N VAL A 312 SHEET 9 A 9 THR A 183 LYS A 186 -1 N GLU A 185 O VAL A 320 SHEET 1 B13 LYS A 72 TYR A 77 0 SHEET 2 B13 GLY A 80 VAL A 93 -1 O GLY A 80 N TYR A 77 SHEET 3 B13 LEU A 96 ASP A 107 -1 O ILE A 106 N SER A 83 SHEET 4 B13 LEU A 40 PRO A 43 1 N LEU A 40 O ILE A 103 SHEET 5 B13 GLY A 122 GLY A 125 -1 O ILE A 123 N TRP A 41 SHEET 6 B13 PRO A 28 ASP A 34 1 N ILE A 32 O LEU A 124 SHEET 7 B13 MET A 15 GLU A 21 -1 N GLY A 18 O PHE A 31 SHEET 8 B13 ASP A 4 PHE A 11 -1 N PHE A 11 O MET A 15 SHEET 9 B13 GLY A 166 ILE A 170 -1 O GLY A 166 N LEU A 8 SHEET 10 B13 LEU A 153 TYR A 157 -1 N THR A 155 O THR A 169 SHEET 11 B13 TYR A 309 ASP A 314 -1 O PHE A 313 N PHE A 154 SHEET 12 B13 SER A 319 LEU A 324 -1 O GLY A 321 N VAL A 312 SHEET 13 B13 THR A 183 LYS A 186 -1 N GLU A 185 O VAL A 320 SHEET 1 C 7 LYS A 265 LEU A 268 0 SHEET 2 C 7 PHE A 257 THR A 260 -1 N PHE A 259 O TYR A 266 SHEET 3 C 7 GLN A 194 HIS A 200 -1 N ASP A 198 O THR A 260 SHEET 4 C 7 MET A 205 ASP A 214 -1 O LEU A 206 N ALA A 199 SHEET 5 C 7 THR A 298 GLY A 302 1 O LEU A 301 N ILE A 212 SHEET 6 C 7 ILE A 220 VAL A 222 -1 N THR A 221 O ILE A 300 SHEET 7 C 7 ILE A 289 GLY A 291 1 O ILE A 290 N VAL A 222 SHEET 1 D 4 ILE A 237 LYS A 238 0 SHEET 2 D 4 TYR A 245 LEU A 248 -1 O VAL A 246 N ILE A 237 SHEET 3 D 4 LEU A 284 LEU A 287 -1 O CYS A 285 N THR A 247 SHEET 4 D 4 LEU A 274 HIS A 276 -1 N GLN A 275 O MET A 286 SHEET 1 E12 THR B 298 LEU B 301 0 SHEET 2 E12 ILE B 204 VAL B 213 1 N ASN B 210 O PHE B 299 SHEET 3 E12 GLN B 194 VAL B 201 -1 N LEU B 197 O ALA B 209 SHEET 4 E12 TYR B 178 HIS B 189 -1 N ASN B 188 O GLN B 194 SHEET 5 E12 SER B 319 ALA B 325 -1 O VAL B 320 N GLU B 185 SHEET 6 E12 TYR B 309 ASP B 314 -1 N ASP B 314 O SER B 319 SHEET 7 E12 LEU B 153 TYR B 157 -1 N PHE B 154 O PHE B 313 SHEET 8 E12 GLY B 166 ILE B 170 -1 O PHE B 167 N TYR B 157 SHEET 9 E12 ASP B 4 PHE B 11 -1 N ILE B 6 O LEU B 168 SHEET 10 E12 MET B 15 VAL B 22 -1 O MET B 15 N PHE B 11 SHEET 11 E12 PRO B 28 ASP B 34 -1 O PHE B 29 N ALA B 20 SHEET 12 E12 GLY B 122 GLY B 125 1 O LEU B 124 N ASP B 34 SHEET 1 F13 LYS B 265 LEU B 268 0 SHEET 2 F13 PHE B 257 THR B 260 -1 N PHE B 259 O TYR B 266 SHEET 3 F13 GLN B 194 VAL B 201 -1 N HIS B 200 O GLU B 258 SHEET 4 F13 TYR B 178 HIS B 189 -1 N ASN B 188 O GLN B 194 SHEET 5 F13 SER B 319 ALA B 325 -1 O VAL B 320 N GLU B 185 SHEET 6 F13 TYR B 309 ASP B 314 -1 N ASP B 314 O SER B 319 SHEET 7 F13 LEU B 153 TYR B 157 -1 N PHE B 154 O PHE B 313 SHEET 8 F13 GLY B 166 ILE B 170 -1 O PHE B 167 N TYR B 157 SHEET 9 F13 ASP B 4 PHE B 11 -1 N ILE B 6 O LEU B 168 SHEET 10 F13 MET B 15 VAL B 22 -1 O MET B 15 N PHE B 11 SHEET 11 F13 GLY B 80 VAL B 93 -1 O THR B 92 N GLU B 21 SHEET 12 F13 LEU B 96 ASP B 107 -1 O GLU B 104 N PHE B 85 SHEET 13 F13 TRP B 41 PRO B 43 1 N VAL B 42 O VAL B 105 SHEET 1 G 5 GLY B 122 GLY B 125 0 SHEET 2 G 5 PRO B 28 ASP B 34 1 N ASP B 34 O LEU B 124 SHEET 3 G 5 MET B 15 VAL B 22 -1 N ALA B 20 O PHE B 29 SHEET 4 G 5 GLY B 80 VAL B 93 -1 O THR B 92 N GLU B 21 SHEET 5 G 5 LYS B 72 TYR B 77 -1 N TYR B 77 O GLY B 80 SHEET 1 H 2 ILE B 220 VAL B 222 0 SHEET 2 H 2 ILE B 289 GLY B 291 1 O ILE B 290 N ILE B 220 SHEET 1 I 4 ILE B 237 LYS B 238 0 SHEET 2 I 4 TYR B 245 LEU B 248 -1 O VAL B 246 N ILE B 237 SHEET 3 I 4 LEU B 284 MET B 286 -1 O CYS B 285 N THR B 247 SHEET 4 I 4 GLN B 275 HIS B 276 -1 N GLN B 275 O MET B 286 SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.70 SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.07 SSBOND 3 CYS B 249 CYS B 285 1555 1555 2.04 CISPEP 1 GLU A 112 PRO A 113 0 5.77 CISPEP 2 GLU B 112 PRO B 113 0 6.12 SITE 1 AC1 11 ASP A 34 GLY A 36 ASN A 76 TYR A 77 SITE 2 AC1 11 VAL A 78 SER A 79 TYR A 192 ASP A 214 SITE 3 AC1 11 GLY A 216 THR A 217 SER A 218 SITE 1 AC2 14 PHE A 241 LEU A 242 ASP B 34 GLY B 36 SITE 2 AC2 14 ASN B 76 TYR B 77 VAL B 78 SER B 79 SITE 3 AC2 14 TYR B 192 ASP B 214 GLY B 216 THR B 217 SITE 4 AC2 14 SER B 218 ILE B 290 CRYST1 141.154 141.154 97.375 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007084 0.004090 0.000000 0.00000 SCALE2 0.000000 0.008180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010270 0.00000